Cancer patients admitted to intensive care unit
Authors:
M. Uchiyama 1; Y. Maezawa 2; H. Satoh 2; R. Hasegawa 1
Authors‘ workplace:
Department of Intensive Care Medicine, Dokkyo Medical University, Saitama Medical Center, Koshigaya, Japan
1; Division of Internal Medicine, Mito Medical Center, University of Tsukuba-Mito, Kyodo General Hospital, Mito, Japan
2
Published in:
Klin Onkol 2026; 39(2): 126
Category:
Letter to Editor
doi:
https://doi.org/10.48095/ccko2026126
Dear Editor,
We read with interest the article by Kraft Rovere et al. published in the October 2025 issue of Klinická onkologie on cancer patients admitted to intensive care unit – a six-year retrospective analysis [1]. We agree with you that it is difficult to determine whether a seriously ill cancer patient should be admitted to the ICU. When deciding whether to admit cancer patients to the ICU for intensive therapy, it is necessary to consider not only whether their life can be saved, but also whether cancer treatment can be continued after ICU treatment. We would appreciate if you could let us know about this point in the cancer patients examined in this study. In particular, as you pointed out, how has the aging population affected ICU therapy for cancer patients? Have there been any changes over time? Please let us know about these points. As the authors described at the end of the discussion, we do agree with your opinion that evaluation of the anti-cancer treatment being administered, the response to treatment, the patient‘s prognosis considering the cancer, and the reversibility of the acute illness are important for admission of IUC therapy in cancer patients. Future studies investigating these items will likely be published. Such information will be important for evaluating the quality of medical care at facilities and for maintaining that quality in the future. We would appreciate if you could build on your results and tell us how else these important findings can be used.
Sources
1. Kraft Rovere R, Pires de Souza ME, Rodrigues Chamse Ddine Y et al. Cancer patients admitted to intensive care unit – a six-year retrospective analysis. Klin Onkol 2025; 38 (5): 381–385. doi: 10.48095/ccko2025381.
Labels
Paediatric clinical oncology Surgery Clinical oncologyArticle was published in
Clinical Oncology
2026 Issue 2
- Safety and Tolerance of Metamizole in Postoperative Analgesia in Children
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
- Obstacle Called Vasospasm: Which Solution Is Most Effective in Microsurgery and How to Pharmacologically Assist It?
- Possibilities of Using Metamizole in the Treatment of Acute Primary Headaches
- Current Insights into the Antispasmodic and Analgesic Effects of Metamizole on the Gastrointestinal Tract
-
All articles in this issue
- Není ct jako CT
- Treatment of Castleman disease from the perspective of the year 2026
- Ewing sarcoma – current diagnostic and therapeutic approaches
- Circulating tumor DNA as a biomarker for the prediction of minimal residual disease and the individualization of adjuvant therapy in colorectal cancer – a review of current evidence and perspectives
- Intravascular propagation of adenomyosis within the blood vessels of the myometrium and uterine leiomyoma in a patient harboring germline mutation in the fumarate hydratase gene – a rare finding simulating malignancy
- Second recurrence of breast cancer 36 years after initial surgery and 18 years after the first recurrence – an extremely rare case
- FDG-PET/CT: metabolically active solitary lesion in the gluteal region subcutaneously in a patient with breast cancer – granuloma or metastasis?
- Cancer patients admitted to intensive care unit
- Nádory GIT – chemoterapie a precizní léčba se synergicky doplňují
- Snižování škod rizikového chování v onkologické prevenci
- AKTUALITY Z NÁRODNÍHO ÚSTAVU PRO VÝZKUM RAKOVINY
- Clinical Oncology
- Journal archive
- Current issue
- About the journal
Most read in this issue
- Treatment of Castleman disease from the perspective of the year 2026
- FDG-PET/CT: metabolically active solitary lesion in the gluteal region subcutaneously in a patient with breast cancer – granuloma or metastasis?
- Ewing sarcoma – current diagnostic and therapeutic approaches
- Intravascular propagation of adenomyosis within the blood vessels of the myometrium and uterine leiomyoma in a patient harboring germline mutation in the fumarate hydratase gene – a rare finding simulating malignancy